Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Jefferies raised its price target on Mercury Systems (NASDAQ:MRCY) to $75.00 from $50.00 on Wednesday, while maintaining a Hold rating on the defense technology company’s shares. The stock, currently trading at $67.15, has surged over 100% in the past year and is approaching its 52-week high of $68.33. According to InvestingPro analysis, Mercury Systems appears overvalued at current levels.
The firm noted that Mercury Systems management has initiated fiscal year 2026 guidance with "somewhat disappointing soft color," which Jefferies suggests contains embedded conservatism regarding delivery timing, similar to the fiscal year 2025 guidance that the company subsequently beat in three quarters. The company’s financial health metrics from InvestingPro show strong price momentum and cash flow scores, with an overall "FAIR" rating.
Jefferies estimates Mercury will achieve approximately 5% revenue growth versus the company’s outlook of low-single-digit growth, potentially enabling modest upside to margins at 15.5% compared to management’s target of "near mid-teens."
The research firm indicated that a return to "normal" Mercury Systems performance with high-single-digit growth and high-teens to low-20% margins remains on hold until fiscal year 2027 and beyond.
The new $75 price target is based on a 24.1x multiple of fiscal year 2027 estimated EBITDA, which Jefferies notes is roughly in line with defense technology peers at 24.2x.
In other recent news, Mercury Systems reported its fourth-quarter fiscal 2025 earnings, revealing a strong performance with earnings per share of $0.47, well above the expected $0.22. The company’s revenue reached $273 million, surpassing the anticipated $243.61 million. This impressive financial performance was supported by a $30 million revenue pull-forward, contributing to record bookings for the company. Truist Securities responded to these results by raising its price target for Mercury Systems to $71, maintaining a Buy rating due to the company’s strong finish to the fiscal year. Meanwhile, Goldman Sachs reiterated a Sell rating on Mercury Systems with a price target of $39, despite the company’s adjusted EBITDA exceeding consensus expectations and showing sequential margin improvement. These developments reflect varied analyst perspectives on Mercury Systems, highlighting differing outlooks on the company’s future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.